fda tirzepatide injection shortage resolved october 2 2024 says years-long is resolved, will give limited leeway to compounders FDA backtracks over Eli Lilly

Update on FDAs ongoing evaluation of reports of suicidal thoughts-or-actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity

What happens if my GLP-1 medication gets too warm during travel

It is an injectable medicine that works through two different methods to aid in weight loss

"Anyone continuing to sell mass compounded tirzepatide is breaking the law and deceiving patients," Lilly said in a company statement sent to NPR

A 2023 pharmaceutical stability study demonstrated that tirzepatide kept at room temperature for 48 hours showed measurable loss of active compound, compromising clinical efficacy and treatment outcomes